Noninvasive Internal Jugular Venous Oximetry
The Development of Novel Noninvasive Internal Jugular Venous Oximetry
The Development of Novel Noninvasive Internal Jugular Venous Oximetry
Sponsor study identifier
observational
100
1 country
1
Study Start
September 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
September 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
In this study, we are developing a novel plethysmographic monitoring device which incorporates several key techniques: inclusion of structural information (ultrasound image), coupling with the estimation of local tissue optical parameters, consideration of the tissue scattering absorption coefficient of each subject, to finally calculate the noninvasive continuous internal jugular venous saturation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 17, 2023
Actual (reported)August 22, 2023
Actual (reported)September 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Internal jugular venous saturation
To validate the estimation of noninvasive internal jugular venous saturation and the real value by obtaing the internal jugular venous blood during central venous catheter placement
20 min
Adult cancer patients without organ dysfunction undergong planned central venous catheter placement for cancer surgery or totally implantable venous access device placement for future chemotherapy. During the central venous line placement, 3 ml blood sample from the internal jugular vein is obtained for internal validation of internal jugular venous saturation for our device.
National Taiwan University Hospital
Taipei, 100, Taiwan
Chun-Yu Wu
National Taiwan University Hospital
First Submitted
August 17, 2023
First Posted
August 22, 2023
Study Start
September 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
September 2024
Estimated (date passed)Individual Food Preferences for the Mediterranean Diet in Cancer Patients
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 22, 2023
Record last verified: 2023-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: